Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings !
Welcome to yet another most pleasant Reading of our newsletter.
Please do not hesitate to mail your comments on this edition to help us further improve so please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
“2020 changed consumer behaviour and, consequently, the advertising industry. The pandemic has been many things but also a transition period where digital consumption increased manifold. Another strong trend was the need for immediate fulfilment of consumer demands and their decreasing tolerance of time taken to do so. We, at ASCI, noticed the early signs of these in 2020 and have been constantly thinking of ways to make our processes faster and more efficient without compromising the integrity of our decisions. The new normal of nowness is challenging and exciting for us too and we are ready to move ahead with the evolving times,”
Manisha Kapoor
ASCI Secretary-General,
Advertising Standards Council of India
Sponsor
Patient Safety Capsules
4,400 Adverse Events Reported In US After Receiving Pfizer-BioNTech Vaccine
WASHINGTON, 7 JAN 2021: Nearly 4,400 adverse events were reported after people received the Pfizer-BioNTech Covid-19 vaccine in the US, with 21 cases determined to be anaphylaxis, according to a report by the Centers for Disease Control and Prevention (CDC).
Consuming Too Much ‘Kadha’ May Have Adverse Effects
New Delhi, 5 Jan 2021: As the world awaits the vaccine for COVID-19, the unprecedented novel Coronavirus continues to rage on. While most lockdown restrictions have been lifted and the country has inched closer to normalcy, a plethora of information on combatting the spread of the virus, preventing potential infection, and safeguarding oneself through the consumption of certain ‘DIY Immunity Boosting Concoctions’ is making the rounds on social media. However, experts are noting a surge in side-effects amongst people who are consuming these homemade 'kadha’s'; the issue being repeated and high dose consumption of these home remedies.
Drug Laws & Policy Injections
Govt Orders 55 Lakh Covaxin Doses, To Cost Rs 295 Per Dose, Says ReportNew Delhi, 11 Jan 2021: Covaxin, the Covid-19 vaccine developed by Hyderabad-based Bharat Biotech, will be sold at ₹295 per dose after a price agreement was arrived at with the government, news agency PTI reported.
NPPA Asks Cos To Provide Data On Issuance Of List Of 324 Overcharging Cases Mumbai, 12 Jan 2021: The National Pharmaceutical Pricing Authority (NPPA) has directed pharmaceutical companies to provide relevant data based on the updated provisional list of 324 overcharging cases under litigation related to Drug Prices Control Order (DPCO) -1979, 1987, 1995 and 2013 violations.
Manufacturers And Marketers Fail To Comply With Rule 84AB Of D&C Act Due To Technical SnagChennai, 12 Jan 2021: The Central government’s repeated attempts to ensure compliance of Rule 84AB of the Drugs and Cosmetics Rules 1945 by manufacturers of licensed facilities and marketers of approved formulations are getting failed time and again since 2019.
Indian Govt Wants Serum Institute To Lower Price Of AstraZeneca Shot, Says SourcesNEW DELHI, 11 JAN 2021: The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, people close to the matter said, delaying the roll-out of the country's immunisation programme.
Health Ministry To Strengthen Role Of AMCs For AEFI Surveillance SystemMumbai, 11 Jan 2021: Even as the country is bracing up for the vaccination for coronavirus, the Union health ministry is in the process of outlining a plan to strengthen the role of 311 adverse drug reaction (ADR) monitoring centers (AMCs) under the Pharmacovigilance Programme of India (PvPI) for the adverse events following immunization (AEFI) surveillance system.
Cipla, Strides Pharma Recall Drugs In The US MarketNew Delhi, 10 Jan 2021: Cipla is recalling over 5.8 lakh packets of esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 40 mg in the US market, as per a report by the US Food and Drug Administration.
Pharma Injections
SII Receives Purchase Order From Government; Vaccine To Cost Rs 200 Per VialNew Delhi, 11 Jan 2021: Serum Institute of India (SII) has received a purchase order from the Central government for 11 million doses of Covishield, the company officials said today.
Sputnik V Vaccine Found Safe In Phase 2 Clinical Trials: Dr Reddy’sHyderabad, 11 Jan 2021: Dr Reddy’s Laboratories has submitted Phase 2 safety data of the Russian Coronavirus disease (Covid-19) vaccine, Sputnik V, to India’s drugs controller general, the company announced on Monday.
Karnataka Govt Withdraws Notification Nominating Practitioners To State Medical Council Bengaluru, 10 Jan 2021: The Karnataka Government has informed the High Court that it is withdrawing its notification nominating a total of five medical practitioners to the Karnataka Medical Council (KMC).
Each Vaccine Vial, With 10 Doses, Must Be Used Within 4 Hours Of Opening Bengaluru, 11 Jan 2021: The initial batches of Covid-19 vaccines, likely to be used beginning January 16, will have to be used or discarded within four hours of the vials — each estimated to contain 10 doses — being opened. The reason: non-availability of vaccine vial monitors (VVMs) because the pandemic situation has prompted the government to do away with the open vial policy that allows storage and use of vaccines for a much longer time even after the vial has been opened.
Covid Decline May Slow Vaccine Efficacy Testing New Delhi, 11 Jan 2021: A sharp drop in the number of covid-19 cases may handicap vaccine developers that are likely to start testing the effectiveness of their shots and potentially delay their approvals in India, where the first phase of the world’s largest immunization programme is set to start next week.
Complaints Rise To 7772 In 2020: ASCI Mumbai, 9 Jan 2021: The Advertising Standards Council of India (ASCI) complaints team looked into 7,772 (4683 direct + 3089 suo moto) complaints against advertisements in 2019-20, as compared to 6,226 complaints in 2018-19.
Drug Dopes
IIT Delhi And AIIA To Jointly Study Ayurvedic FormulationsNEW DELHI, 5 JAN 2021: The Indian Institute of Technology (IIT) Delhi announced in a press release that it would work with the All India Institute of Ayurveda (AIIA), New Delhi to work on seven collaborative projects that focus on the uses and efficacy of Ayurvedic formulations and drugs. 
NPPA Caps Retail Prices Of Seven FormulationsMumbai, 5 Jan 2021: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of seven formulations under Drugs Prices Control Order (DPCO) - 2013 relating to 82nd Authority meeting dated December 23, 2020.
Serum, Bharat Biotech Jointly Pledge For Smooth Vaccine Roll Out New Delhi, 5 Jan 2021: Serum Institute and Bharat Biotech on Tuesday issued a joint statement pledging to provide their Covid-19 vaccines to India and globally.
Centre Warns About Fake Co-WIN Apps New Delhi, 7 Jan 2021: The Union health ministry on Wednesday warned people about fake mobile applications that sound similar to the upcoming official application, Co-WIN, and asked them not to download or share personal information on these apps.
MGMMC Indore To Begin NAT Testing To Detect Hepatitis, HIV INDORE, 9 JAN 2021: Blood and transfusion medicine department of MGMMC is all set to begin first Nucleic Acid Amplification Testing (NAT) in division for detecting presence of viral diseases like hepatitis C in collected blood samples.
Covid Management Under CAG ScannerNEW DELHI, 10 JAN 2021: The Comptroller and Auditor General has started an audit on Covid-19 pandemic management, with field studies in eight states to evaluate procurement and availability of drugs and equipment and paramedics in public health centres and efficacy of the first response system in hinterlands.
National Injections
First Covishield Vaccines Consignment Leaves Serum Institute's Facility PUNE, 12 JAN 2021: A decisive phase in India's fight against coronavirus began in the wee hours on Tuesday as the first consignment of Covishield vaccines left Serum Institute of India for Pune airport, four days ahead of the nationwide inoculation drive launch.
Karnataka High Court Quashes Case Against SnapdealBengaluru, 8 Jan 2021: The Karnataka High Court has ruled that an intermediary as defined under the Information Technology Act or its directorswould not be liable for any action or inaction on part of a vendor/seller making use of the facilities provided by the intermediary in terms of a website or a marketplace.
Experts Recommend CDS Platforms To Help Clinicians Make Informed Therapy Decisions Mumbai, 9 Jan 2021: Experts have recommended robust Clinical Decision Support (CDS) platforms to evaluate the quality of clinical evidence to help clinicians make informed therapy decisions. It will avoid medical errors and adverse events during treatment, besides being a cost-effective tool.
41 Destinations Finalised For Covid Vaccine Delivery New Delhi, 7 Jan 2021: The transportation of coronavirus vaccines might begin today or tomorrow, news agency ANI quoted government sources as saying.
DoP Issues Revised PPO Guidelines Mumbai, 7 Jan 2021: In order to promote the manufacturing and production of pharmaceutical goods and services in India, the Department of Pharmaceuticals (DoP) has issued revised guidelines of Public Procurement Order (PPO) 2017 for the procurement of goods and services in pharma formulations. The move will further encourage ‘Make in India’ and will enhance income and employment in the country.
NPPA Plans To Raise ‘Public Health’ Concerns Over Cocktail Drugs Before Govt New Delhi, 30 Dec 2020: Drug price watchdog National Pharmaceutical Pricing Authority (NPPA) has decided to raise concerns on drug cocktails before the Ministry of Health and Family Welfare, two months after it called for flagging the issue to the Indian Council of Medical Research (ICMR).
Global Injections
Britain Working With Pfizer, AstraZeneca To Increase Vaccine SuppliesLONDON, 7 JAN 2021: Britain's rollout of Covid-19 vaccines is being limited by the supply of shots, and the government is working with both Pfizer and AstraZeneca to increase supplies, health minister Matt Hancock said on Thursday. "The rate-limiting step is the supply of vaccine, and we're working with the companies, both Pfizer and of course AstraZeneca, to increase the supply,"
New Coronavirus Variant Could Trigger False Negatives Among Gold-Standard Tests: US FDAMaryland, 8 Jan 2021: The FDA is alerting healthcare professionals that mutations in the novel coronavirus’s genetic code—such as the type powering the fast-spreading variant identified in the U.K.—can trigger false negative results in gold-standard COVID-19 tests.
Pralatrexate Outperforms Remdesivir Against Covid Virus
Beijing, 2 Jan 2021: A chemotherapy medication originally developed to treat lymphoma has outperformed the popular remdesivir drug against SARS-CoV-2 in lab settings, and could potentially be repurposed to treat Covid-19, say researchers.
Focus On Boosting Supply Chain For Medical Devices
New Delhi, 2 Jan 2021: India took less than a year to become self-reliant in the manufacture of medical devices, personal protective equipment (PPE), and ventilators following the coronavirus outbreak and now seeks to strengthen the global supply chain by ensuring quality, according to industry experts.
New Research May Explain Severe Virus Attacks On The Lungs
Stockholm, 30 Dec 2020: In some cases, immune cells in the lungs can contribute to worsening a virus attack. In a new study, researchers at Karolinska Institutet in Sweden describe how different kinds of immune cells, called macrophages, develop in the lungs and which of them may be behind severe lung diseases. The study, which was published in Immunity, may contribute to future treatments for COVID-19, among other diseases.
Study Uncovers Blood Vessel Damage, Inflammation In COVID-19 Patients' Brains
Washington, 31 Dec 2020: In an in-depth study of how Covid-19 affects a patient’s brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease.
PSAIIF PILL
Pharma Exports Get A Boost As Nations Depend Less On China
Mumbai, 7 Jan 2021: India’s domestic pharma companies have seen their exports, especially of anti-viral drugs such as hydroxychloroquine (despite its weak evidence in curing Covid-19) Favipiravir and Remdesivir, to non-regulated markets grow as several countries chose to cut down their exposure to China, data from rating agency CRISIL and the ministry of commerce showed.
Centre Brings In Consolidated Guidance On Biomedical Waste Management
Bengaluru, 4 Jan 2021: The Union government has now brought in a consolidated guidance on biomedical waste management in a bid to create uniformity in the existing biomedical waste management norms of the Central Pollution Control Board (CPCB), Kayakalp and the routine immunization.
Frequently Asked Questions
The Advantage of Indian Companies Garnering 45% Of ANDA Approvals During Last 9 Months?
Mumbai, 2 Jan 2021: The Indian pharmaceutical companies will benefit from an improving demand from the US market, as they have garnered 45 per cent of all new ANDA (abbreviated new drug application) approvals over the past nine months, stated India Ratings and Research.. Read More>>>
SUBSCRIBER'S SYMPTOM
Why Agra Is Fast Turning Into A Narcotics Hub
New Delhi, 3 Jan 2021: Agra, best known for the Taj Mahal and Fatehpur Sikri, is now a bustling hub for the narcotics trade. It seems the traffickers are using the city, just 231 km south-east of the national capital, to store narcotics in huge quantities. Several instances have come to light in the past few months of drug syndicates hiring warehouses to stock large quantities of synthetic drugs, including Tramadol pain relief injections and Alprazolam tablets.resolved.
Blog Addicts
Dr Krishna Joshi, MD It is always a great pleasure reading the articles published in this newsletter. Keeping the reader engrossed with current pertinent topics is really welcoming.
Ms Geetanjali Singh, IT ProfessionalAlways look forward to the newsletter editions every month for an interesting read. Great work!
Ms Himani Gandhi, Professional
"The Prescription" is a much awaited dose for my monthly consumption of important pharma developments and news. Well done!
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
